Kwit v. Walgreen Co. et al
| Peter Kwit |
| GlaxoSmithKline Holdings (Americas), Inc., Walgreen Co., Walgreens Boots Alliance, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi-Aventis U.S. LLC, Sanofi U.S. Services, Inc. and John Does 1-100 Inclusive |
| 1:2023cv13949 |
| September 20, 2023 |
| US District Court for the Northern District of Illinois |
| LaShonda A Hunt |
| Personal Inj. Prod. Liability |
| 28 U.S.C. § 1332 Diversity-Petition for Removal |
| Defendant |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 6, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 26 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC (Fakhouri, Rami) |
| Filing 25 ATTORNEY Appearance for Defendants GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC by Rami N Fakhouri (Fakhouri, Rami) |
| Filing 24 ATTORNEY Appearance for Plaintiff Peter Kwit by John Anthony Bruegger (Bruegger, John) |
| Filing 23 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Sanofi U.S. Services, Inc. (Roselius, Joseph) |
| Filing 22 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Sanofi-Aventis U.S. LLC (Roselius, Joseph) |
| Filing 21 ATTORNEY Appearance for Defendants Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC by Joseph Anton Roselius (Roselius, Joseph) |
| Filing 20 MINUTE entry before the Honorable LaShonda A. Hunt: Plaintiff's Motion to Remand #18 is taken under advisement. The Court will not set a briefing schedule unless the conditional transfer to the MDL is resolved in favor of the instant action remaining before this Court. Emailed notice. (cdh, ) |
| Filing 19 ATTORNEY Appearance for Defendant Pfizer, Inc. by Stephanie Ann Scharf (Scharf, Stephanie) |
| Filing 18 MOTION by Plaintiff Peter Kwit to remand and Memorandum of Law (Attachments: #1 Exhibit, #2 Exhibit, #3 Exhibit, #4 Exhibit, #5 Exhibit)(Bruegger, John) |
| Filing 17 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Pfizer, Inc. (Sax, George) |
| Filing 16 ATTORNEY Appearance for Defendant Pfizer, Inc. by George D Sax (Sax, George) |
| Filing 15 NOTICE by Peter Kwit of Filing Opposition to Conditional Transfer Order (CTO-119) with JPML (Attachments: #1 Exhibit)(Bruegger, John) |
| Filing 14 MINUTE entry before the Honorable LaShonda A. Hunt: In light of the Conditional Transfer Order filed on 10/2/23 (In re Zantac (Ranitidine) Products Liability Litigation, MDL Case No. 2924, Dkt. 1339), the Court strikes the initial status hearing of 10/17/23, as well as the briefing schedule on Removing Defendants' Motion to Stay All Proceedings Pending Transfer to Multidistrict Litigation #9 . The Court will not set any further dates until the conditional transfer to the MDL is resolved. Emailed notice. (cdh, ) |
| Filing 13 MINUTE entry before the Honorable LaShonda A. Hunt: Removing Defendants' Motion to Stay All Proceedings Pending Transfer to Multidistrict Litigation #9 will be heard at the initial status hearing set for 10/17/23. Plaintiff may file a brief in opposition by 10/10/23. No reply brief will be allowed without leave of court. Removing Defendants' Motion for Extension of Time to Respond to Plaintiff's Complaint #8 is granted. The deadline for Removing Defendants' responsive pleading is stayed until the Court resolves the issues related to the potential transfer to the Zantac multi-district litigation. Emailed notice. (cdh, ) |
| Filing 12 NOTICE of Correction regarding Patent/Trademark report #11 . (rc, ) |
| Filing 11 Entered in Error. (rc, ) Modified on 9/27/2023 (rc, ). |
| Filing 10 MAILED Notice of Removal letter to counsel of record. (rc, ) |
| Filing 9 MOTION by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC to stay All Proceedings Pending Transfer to Multidistrict Litigation (Opposed) (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D)(Zousmer, Julia) |
| Filing 8 MOTION by Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation, GlaxoSmithKline Holdings (Americas), Inc., GlaxoSmithKline, LLC, Pfizer, Inc., Sanofi U.S. Services, Inc., Sanofi-Aventis U.S. LLC for extension of time to file answer (Zousmer, Julia) |
| CLERK'S NOTICE: Pursuant to Local Rule 73.1(b), a United States Magistrate Judge of this court is available to conduct all proceedings in this civil action. If all parties consent to have the currently assigned United States Magistrate Judge conduct all proceedings in this case, including trial, the entry of final judgment, and all post-trial proceedings, all parties must sign their names on the attached #Consent To# form. This consent form is eligible for filing only if executed by all parties. The parties can also express their consent to jurisdiction by a magistrate judge in any joint filing, including the Joint Initial Status Report or proposed Case Management Order. (rc, ) |
| Filing 7 MINUTE entry before the Honorable LaShonda A. Hunt: This case has been assigned to the calendar of Judge LaShonda A. Hunt. After reviewing the notice of removal #1 , in which plaintiffs contend that diversity jurisdiction is satisfied notwithstanding the existence of non-diverse defendants, the Court has some reservations about whether this action can proceed in federal court. However, at this juncture, Plaintiff has not yet entered an appearance, let alone indicated whether he will seek to remand the case to state court. A telephonic initial status hearing is set for 10/17/23 at 9:30 AM. Attorneys/Parties should appear for the hearing by calling the Toll-Free Number: 877-336-1828, Access Code: 4082461. Members of the public and media may call in to listen to the hearing. Persons granted remote access to proceedings are reminded of the general prohibition against photographing, recording, and rebroadcasting court proceedings. Emailed notice. (cdh, ) |
| Filing 6 ATTORNEY Appearance for Plaintiff Peter Kwit by John Anthony Bruegger (Special and Limited Entry of Appearance) (Bruegger, John) |
| Filing 5 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation (Zousmer, Julia) |
| CASE ASSIGNED to the Honorable LaShonda A. Hunt. Designated as Magistrate Judge the Honorable Jeffrey Cole. Case assignment: Random assignment. (jxm, ) |
| Filing 4 ATTORNEY Appearance for Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation by Christopher Patrick Eby (Eby, Christopher) |
| Filing 3 ATTORNEY Appearance for Defendants Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation by Julia Ruth Zousmer (Zousmer, Julia) |
| Filing 2 CIVIL Cover Sheet (Zousmer, Julia) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2023-L-007872) filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corporation Filing fee $ 402, receipt number AILNDC-21118460. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Exhibit G, #8 Exhibit H, #9 Exhibit I, #10 Exhibit J, #11 Exhibit K)(Zousmer, Julia) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
